The Women's Health Research Unit at OHSU

The Women's Health Research Unit at OHSU Clinical trials at Oregon Health and Science University are advancing treatments in women's health - Finding new solutions to old problems!

The OHSU Women's Health Research Unit is an important part of the OHSU Center for Women's Health. Our team of researchers conducts numerous research projects related to women's health. The Women's Health Research Unit at Oregon Health and Science University in Portland, Oregon, is actively recruiting patients for clinical trials. The purpose of our page is to foster a conversation between our department and the community. We want to hear your comments, experiences, and feedback however we ask that conversations be respectful. In an effort to ensure that conversations are constructive for our followers we may delete offensive comments, spam, or suspected spam. We strive to maintain a safe place for our followers to contact us and share their views and questions. Although the information we share online is about health, we cannot provide medical advice for your personal health situation. If you have a medical issue that requires advice or treatment, we encourage you to contact your primary care provider. For more information, please read our disclaimer: http://www.ohsu.edu/xd/about/contact-us/disclaimer.cfm

For more information about participating in one of the focus group discussions, please contact us at whru@ohsu.edu.
09/09/2025

For more information about participating in one of the focus group discussions, please contact us at whru@ohsu.edu.

New publication alert!👩‍🔬🔬📄The results highlighted in the Business Wire's publication "Bayer's elinzanetant meets all pr...
01/29/2024

New publication alert!👩‍🔬🔬📄

The results highlighted in the Business Wire's publication "Bayer's elinzanetant meets all primary and key secondary endpoints in pivotal OASIS 1 and 2 Phase 3 studies" bring us one step closer to providing effective solutions for folks experiencing menopausal symptoms.

Read more- https://urldefense.com/v3/__https:/www.businesswire.com/news/home/20240108102481/en/Bayer**Bs-elinzanetant-meets-all-primary-and-key-secondary-endpoints-in-pivotal-OASIS-1-and-2-Phase-III-studies__;4oCZ!!Mi0JBg!NNDWH_Yvzf1Z9b9VpUR05dovdZ9qI5x2dJohmdvn-yxi52RfmpTksa1Ql3UD6Y-VVC5Fxrdx9sPvj_6AZ3BkqpaiWw$

Comunidad, todos están invitados a unirse a nuestra Unidad de Investigación de Salud de la Mujer en OHSU en nuestra prox...
11/03/2023

Comunidad, todos están invitados a unirse a nuestra Unidad de Investigación de Salud de la Mujer en OHSU en nuestra proxima mesa informativa. Se llevará a cabo mañana 4 de noviembre de 9:00 a.m. a 3:00 p.m. ¡Es un evento gratuito de feria de salud organizado por Telemundo Portland ! Estaremos ubicados en el tejaban #40.

Community, you are all invited to join our The Women's Health Research Unit at OHSU in our upcoming tabling event. It will be held tomorrow, November 4th from 9:00AM to 3:00PM. It is a free health fair event being hosted by Telemundo Portland! We will be located in booth #40.

On Monday, October 30th our Women's Health and Pregnancy Research teams volunteered at the Oregon Food Bank! All 10 of u...
11/03/2023

On Monday, October 30th our Women's Health and Pregnancy Research teams volunteered at the Oregon Food Bank! All 10 of us had an amazing time. We were able to assort and help unpack 6 pallets with other members of the community. This equates to 2,400 pounds of tea total 🥳!

The tea will be distributed to food banks across our state🫖🚛!

Thank you Oregon Food Bank for having us! We look forward to volunteering with you in the future!

Contraceptive Announcement!✨First FDA-Approved Over-the-Counter Daily B.C. Pill ✨Our OB/GYN Department Women's Health Re...
07/24/2023

Contraceptive Announcement!

✨First FDA-Approved Over-the-Counter Daily B.C. Pill ✨

Our OB/GYN Department Women's Health Research Unit and those individuals who volunteered to participate in the research were an integral part of the approval process. They were part of a sponsored research study that provided critical research needed for this application (over the counter approval requires some different information than an initial drug approval.

💊The pill won’t likely be available until early 2024 but it will be the most effective contraceptive method available to consumers without a prescription! 💊

🧐For more information, check out Perrigo's announcement- https://investor.perrigo.com/2023-07-13-Perrigo-Announces-U-S-FDA-Approval-for-Opill-R-OTC-Daily-Oral-Contraceptive

🌟 Highlighting our Providers🌟Alyssa Colwill, M.D., assistant professor in the OHSU School of Medicine and Bethany Samuel...
05/26/2023

🌟 Highlighting our Providers🌟
Alyssa Colwill, M.D., assistant professor in the OHSU School of Medicine and Bethany Samuelson Bannow, M.D., assistant professor within the OHSU division of hematology/medical oncology, are investigating the use of alternative menstrual products.

🩸To read the full article, visit the following link:https://news.ohsu.edu/file/menstrual-technology-main-crop?action=
🩸Learn more about our heavy menstrual bleeding studies:https://ohsu.edu/womens-health/currently-enrolling-studies

Source: OHSU Now -https://news.ohsu.edu/file/menstrual-technology-main-crop?action=

✨Check out this new study!✨Have you been diagnosed with a complicated vaginal yeast infection? We have a study you may b...
03/10/2023

✨Check out this new study!✨

Have you been diagnosed with a complicated vaginal yeast infection? We have a study you may be eligible to participate in.

We are studying how well a new drug works to treat complicated vaginal yeast infections. We are specifically recruiting people who have not had success with fluconazole therapy.

Participants will be compensated up to $698.25 ($99.75 a visit) for out of pocket expenses such as travel and parking.

If you are interested, please contact us via our confidential recruitment line at 503-494-3666 or email us at whru@ohsu.edu!

Principal Investigator: Catherine Leclair, MD
eIRB #: 00024702

🩸Do you have heavy periods? Join a research study to help diagnose heavy periods!🩸🩸In order to diagnose heavy periods, h...
01/26/2023

🩸Do you have heavy periods? Join a research study to help diagnose heavy periods!🩸

🩸In order to diagnose heavy periods, healthcare providers typically depend on information like how often disposable pads or tampons are changed.
🩸Many people prefer to use menstrual cups and/or period underwear, so we need information on how frequent individuals with heavy periods empty cups or saturate underwear.
🩸 This study does not require medications. Participants must be comfortable using different period products (i.e menstrual cup or period underwear)

To find out more information and to learn if you are qualified to participate, please contact the Women's Health Research Unit confidential recruitment line at 503-494-3666, email whru@ohsu.edu, or visit https://www.ohsu.edu/womens-health/diagnosis-heavy-menstrual-bleeding-using-alternative-period-products
PI: Bethany Samuelson Bannow, MD; IRB:23668

12/02/2022

Do you or someone you know have endometriosis? If so, please check out the post below!

Our Women’s Health Research Unit is accepting new participants with endometriosis. An overview of endometriosis and our studies are as follows.

Endometriosis Overview
Endometriosis is a common condition in people who menstruate. It can cause significant pelvic and abdominal pain. It occurs when endometrial cells implant in area other than the lining of the uterus. Sometimes it lead to problems getting pregnant and sometimes it impacts people so much that they can't go to school or work on the days that experience pain. People with endometriosis can have pain with s*x, pain with urination and bowel movements, and other symptoms. For more information about endometriosis here is a good resource: ACOG: Endometriosis- https://www.acog.org/womens-health/faqs/endometriosis?utm_source=redirect&utm_

The Women's Health Research Unit is Currently seeking participants in two clinical trials looking at treatment for people with endometriosis. More information on each study is below.

• Endometriosis Related-Pain Study- This study is being done in order to investigate a novel investigational non-hormonal, injectable experimental drug which may relive moderate to severe endometriosis-associated pain. An experimental drug is one that is not approved by the United States Food and Drug Administration (FDA). The drug works by binding to, and blocking the function of prolactin receptors. Prolactin is a hormone that stimulates milk production after childbirth. This study is intended to find out if this new drug works and is safe for women with endometriosis-associated pain.

• Myovant SERENE Study- The drug we are studying is a GnRH receptor antagonist combined with estrogen and progesterone. In this study we want to learn if the investigational drug is a safe and effective option for pregnancy prevention specifically in women with uterine fibroids and endometriosis. If enrolled, you will receive the medication being tested in this study for one year. The study drug is taken by mouth once daily. You will not be allowed to use any other form of birth control for the duration of the study including condoms or withdrawal/”the pull-out method”.

If you have any questions and/or are interested in any of our studies, please contact the Women’s Health Research Unit’s confidential recruitment line at 503-494-3666 or email whru@ohsu.edu.

Address

3181 SW Sam Jackson Park Road
Portland, OR
97239

Opening Hours

Monday 8am - 4pm
Tuesday 8am - 4pm
Wednesday 8am - 4pm
Thursday 8am - 4pm
Friday 8am - 4pm

Telephone

(503) 494-3666

Alerts

Be the first to know and let us send you an email when The Women's Health Research Unit at OHSU posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Women's Health Research Unit at OHSU:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram